Web Analytics

Start up Profile

CardioMech AS

CardioMech AS Norway - Trondheim
START UP

1 Disclosed Funding Rounds $13,000,000
0 Participating Investments




Mitral Regurgitation is the third most common cardiovascular disease that occurs when there is backward flow of blood across the mitral valve. It is highly prevalent, debilitating for patient

Capital Raised

Date Round Raised Participating Investors
January, 03 ,2024 Unknown $13,000,000